Clinical Trial Update: Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating megadose hydroxocobalamin for pernicious anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Megaloblastic Anemia
• Pernicious Anemia

Drugs mentioned

• Hydroxocobalamin (Hydroxocobalamin)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Megaloblastic Anemia Nos, Pernicious Anemia | Phase 4 | Status: COMPLETED